FIELD: biotechnology.
SUBSTANCE: present invention relates to novel therapeutic peptides and can be used in medicine. Invention discloses a new peptide analogue of glucose-dependent insulinotropic polypeptide (GIP), modified by inclusion of one or more separate amino acid substitutions and conjugated with a fatty acid with or without a linker to provide increased antagonist activity and an improved pharmacokinetic profile.
EFFECT: invention can be used in medical practice for prevention or treatment of various metabolic diseases.
15 cl, 1 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR TREATING HYPERLIPIDEMIA CONTAINING AN OXYNTOMODULIN DERIVATIVE | 2013 |
|
RU2768853C1 |
| PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53 | 2017 |
|
RU2762089C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| ANTI-TIGIT ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732591C2 |
| ANTIBODIES TO TAU AND THEIR USE | 2018 |
|
RU2787779C2 |
| COMBINED MEDICINAL PRODUCTS TARGETING PD-1, TIM-3 AND LAG-3 | 2018 |
|
RU2795232C2 |
| HYBRID PROTEINS AND METHODS OF STIMULATING PLANT GROWTH, PROTECTING PLANTS AND IMMOBILIZING BACILLUS SPORES ON PLANTS | 2014 |
|
RU2815587C2 |
| USE OF OPTIONS OF NATRIURETIC PEPTIDE OF TYPE C FOR TREATMENT OF OSTEOARTHRITIS | 2016 |
|
RU2759679C2 |
| PLATFORM BASED ON CYSTEINE KNOT SCAFFOLD | 2016 |
|
RU2770384C2 |
